Sanvar Approval Status
FDA Approved: No
Brand name: Sanvar
Generic name: vapreotide acetate
Company: Debiovision Inc.
Treatment for: Esophageal Varices with Bleeding
Sanvar (vapreotide acetate) is a somatostatin analogue in development for the treatment of acute esophageal variceal bleeding (EVB).
Development Status and FDA Approval Process for Sanvar
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.